Related Articles
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)
Progress of immune checkpoint therapy in the clinic (Review)
Immunological status of peripheral blood is associated with prognosis in patients with bone and soft-tissue sarcoma
Exploration of novel clusters and prognostic value of immune‑related signatures and identify HAMP as hub gene in colorectal cancer
Clinical predictors of response to single‑agent immune checkpoint inhibitors in chemotherapy‑pretreated non‑small cell lung cancer